Table Of Contents
1 Introduction 17
1.1 Objectives Of The Study 17
1.2 Market Definition 17
1.3 Overview Of Asia-Pacific Transfection Reagents And Equipment Market 17
1.4 Currency And Pricing 18
1.5 Limitation 18
1.6 Markets Covered 19
2 Market Segmentation 21
2.1 Markets Covered 21
2.2 Geographic Scope 22
2.3 Years Considered For The Study 23
2.4 Currency And Pricing 23
2.5 Research Methodology 24
2.6 Primary Interviews With Key Opinion Leaders 27
2.7 The Category Vs Time Grid 28
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes 34
3.1.2 Increasing R&D Spending And Research Activities By Pharmaceutical And Biotech Companies 35
3.1.3 Technological Advancements In Transfection Technology 36
3.1.4 Alliances Between The Leading Research Institutes To Trigger Drug Discovery 37
3.1.5 Rising Prevalence Of Chronic Indications 37
3.2 Restraints 39
3.2.1 Selective Effectiveness Of Transfection Reagents Or Instruments 39
3.2.2 High Cost Of Transfection Reagents And Equipment 39
3.2.3 Home Brew Reagents Limits The Sale Of Commercial Kits 41
3.3 Opportunities 42
3.3.1 Efficient Nuclear Delivery Method 42
3.3.2 Emerging Markets 42
3.4 Challenges 44
3.4.1 Slow Rate Of Transfection In Hard Cells 44
3.4.2 Cytotoxicity Effects Due To Transfection Reagents 44
4 Executive Summary 45
5 Premium Insights 47
6 Asia-Pacific Transfection Reagents And Equipment Market, By Product 50
6.1 Overview 51
6.2 Reagent 53
6.3 Equipment 54
7 Asia-Pacific Transfection Reagents And Equipment Market, By Method 55
7.1 Overview 56
7.2 Physical Method 58
7.2.1 Electroporation 59
7.2.2 Nucleofection 59
7.2.3 Others 59
7.2.3.1 Genegun 60
7.2.3.2 Magnetofection 60
7.2.3.3 Sonoporation 60
7.2.3.4 Optoinjection 60
7.3 Biochemical Methods 61
7.3.1 Lipofection 62
7.3.2 Calcium Phosphate 62
7.3.3 Deae-Dextran 62
7.3.4 Dendrimers 62
7.4 Viral Method 63
7.4.1 Retroviruses 64
7.4.2 Adenoviruses 64
7.4.3 Adenoassociated Viruses 64
7.4.4 Others 64
8 Asia-Pacific Transfection Reagents And Equipment Market, By Application 65
8.1 Overview 66
8.2 Protein Production 68
8.3 Biomedical Research 69
8.3.1 Gene Expression Studies 70
8.3.2 Cancer Research 70
8.3.3 Transgenic Models 70
8.4 Therapeutic Delivery 71
9 Asia-Pacific Transfection Reagents And Equipment Market, By End User 72
9.1 Overview 73
9.2 Academics & Research Institutes 75
9.3 Pharmaceutical & Biotechnology Companies 76
10 Asia-Pacific Transfection Reagents And Equipment, By Geography 77
10.1 Asia-Pacific 77
10.1.1 China 89
10.1.2 Japan 94
10.1.3 South Korea 99
10.1.4 India 104
10.1.5 Singapore 109
10.1.6 Australia 114
10.1.7 Thailand 119
10.1.8 Malaysia 124
10.1.9 Indonesia 129
10.1.10 Philippines 134
10.1.11 Rest Of Asia-Pacific 139
11 Asia-Pacific Transfection Reagents And Equipment Market, Company Landscape 140
11.1 Company Share Analysis; Asia-Pacific 140
12 Company Profile 141
12.1 Thermo Fisher Scientific Inc. 141
12.1.1 Company Overview 141
12.1.2 Revenue Analysis 141
12.1.3 Company Share Analysis 142
12.1.4 Product Portfolio 142
12.1.5 Recent Developments 143
12.2 Sigma-Aldrich, Inc. (Subsidiary Of Merck Kgaa) 144
12.2.1 Company Overview 144
12.2.2 Geographical Presence 144
12.2.3 Company Share Analysis 145
12.2.4 Product Portfolio 145
12.2.5 Recent Developments 145
12.3 Promega Corporation 146
12.3.1 Company Overview 146
12.3.2 Geographical Presence 146
12.3.3 Company Share Analysis 147
12.3.4 Product Portfolio 147
12.3.5 Recent Developments 147
12.4 Qiagen 148
12.4.1 Company Overview 148
12.4.2 Revenue Analysis 148
12.4.3 Company Share Analysis 149
12.4.4 Product Portfolio 149
12.4.5 Recent Developments 150
12.5 Bio-Rad Laboratories, Inc. 151
12.5.1 Company Overview 151
12.5.2 Revenue Analysis 151
12.5.3 Product Portfolio 152
12.5.4 Recent Developments 152
12.6 Genlantis Inc. 153
12.6.1 Company Overview 153
12.6.2 Geographical Presence 153
12.6.3 Product Portfolio 154
12.6.4 Recent Developments 154
12.7 Lonza 155
12.7.1 Company Overview 155
12.7.2 Revenue Analysis 155
12.7.3 Product Portfolio 156
12.7.4 Recent Developments 157
12.8 Maxcyte Inc 158
12.8.1 Company Overview 158
12.8.2 Geographical Presence 158
12.8.3 Product Portfolio 159
12.8.4 Recent Developments 159
12.9 Mirus Bio Llc 160
12.9.1 Company Overview 160
12.9.2 Geographical Presence 160
12.9.3 Product Portfolio 161
12.9.4 Recent Developments 162
12.10 Polyplus Transfection 163
12.10.1 Company Overview 163
12.10.2 Geographical Presence 163
12.10.3 Product Portfolio 164
12.10.4 Recent Developments 164
12.11 Signagen Laboratories. 165
12.11.1 Company Overview 165
12.11.2 Geographical Presence 165
12.11.3 Product Portfolio 166
12.11.4 Recent Development 166
13 Related Reports 167
?